Resources
About Us
Home Report
Store
Microfluidic Immunoassay Market
Microfluidic Immunoassay Market Size, Share, Forecast, & Trends Analysis by Product (Cartridge [Polymer, Glass], Reagent, System) Technology (Electrochemical, Optical) Application (Cardiology, Oncology, Infectious Disease) End User—Global Forecast to 2031
Report ID:MRHC - 104334 Pages: 259 Jan-2024 Formats*: PDF Category: Healthcare Delivery: 2 to 4 HoursThe Microfluidic Immunoassay Market was valued at $0.92Â billion in 2023. This market is expected to reach $1.59Â billion by 2031, from an estimated $0.98Â billion in 2024, at a CAGR of 7.3% during the forecast period 2024-2031.
Microfluidic Immunoassay Market Size & Forecast
The growth of this market is driven by the increasing use of microfluidic immunoassays in drug discovery & development and biomarker detection, the advantages of lab-on-chip immunoassays over conventional immunoassays, pharmaceutical & biotechnology companies’ increasing focus on research & development, and the miniaturization of biological and chemical assays. Moreover, the increasing demand for point-of-care diagnostics and recent advancements in microfluidic immunoassay technology are expected to generate market growth opportunities.
Microfluidic Immunoassay Market Growth Drivers
Increasing Use of Microfluidic Immunoassay in Biomarker Detection and Drug Discovery & Development
Pharmaceutical and biotechnology companies allocate significant resources to research. Microfluidic immunoassay is majorly used for the detection of biomarkers associated with diseases for understanding disease mechanism for drug development and disease detection. Microfluidic immunoassays have become increasingly important in maintaining precision and accuracy in drug research & development and reducing the time required for research.
Numerous drug discovery processes can benefit from the use of microfluidics, including drug compound synthesis, screening, delivery, and the development of carrier systems. Microfluidic immunoassays have applications in drug screening due to their benefits, such as improved throughput, reduced consumption of reagents, automation, reduced reaction time, seamless integration and parallelization, simplification of operational steps, and reduced waste generation.
Pharmaceutical and biotechnology companies combine microfluidic immunoassays with various detection technologies for high-throughput screening and the detection and mechanistic study of drugs. The players operating in this market are collaborating to develop advanced microfluidic immunoassay products.
Click here to:Â Get Free Sample Pages of this Report
Increasing Funding for Microfluidic Immunoassay Research
Microfluidics sector is gaining traction in recent years owing to the ongoing research in the field and increasing applications in drug discovery and diagnostics. The key players operating in the market and government agencies are providing funding and grants for the research.
- In April 2022, India’s Ministry of Electronics & Information Technology provided USD 0.1 million (INR 93 Lakhs) has provided the funding for the ‘Microfluidic Point-of-Care System for Molecular Diagnostics’ project. The project is a part of the Centre of Excellence in Nanoelectronics: Phase -III (CeNSE). The project timeline was announced as 15-04-2018 to 14-04-2022. However, the project has been extended and is still ongoing.
- In November 2021, Parallel Fluidics (U.S.), a manufacturer of microfluidic devices, raised USD 1.8 million in a round of financing from technologists, investors, and founders. The company planned to use this funding to increase its capacity and capability in manufacturing microfluidics devices.
Microfluidic Immunoassay Market Trends
Multiplexed Panel Detection
In many cases, a single molecular event is inadequate to indicate the pathophysiology of diseases such as cancer. The adoption of multiplexed diagnostic testing has increased due to its benefits, such as reduced reagent consumption, multiple analyte detection, improved sensitivity, and shorter reaction time. Therefore, microfluidic detection of multiple analytes in a single test has become a growing trend. Many companies are developing multiple-analyte tests to expand their LOC portfolios. POC-based multi-analyte testing for infectious microorganisms could be useful in diagnosing diseases and initiating treatment, as getting results for a laboratory culture-based analysis would be time-consuming, and a single parametric test may not provide accurate diagnosis. A single lab-on-chip device enabling the diagnosis of the most common sexually transmitted diseases in a single run can save time and money.
Paper-based Microfluidics
Microfluidics technology integrates entire lab procedures on a single chip. Therefore, the technology has generated significant interest in recent years, mainly due to the reduced requirement of cumbersome instruments. Lab-on-chip technology has evolved over nearly two decades, with various materials used in the design and manufacture of the devices. Paper is gaining much traction as the material of choice for manufacturing microfluidics based POC cartridges, mainly due to the advantages of paper, such as low costs and affordability, compatibility with several medical applications, and ability to transport fluid (through capillary forces) without needing any external forces. Presently, both industry and academia are focused on research into paper-based microfluidics. The study published in 2022, presents the development of a paper-based microfluidic device capable of remote biofluid collection, followed by an analysis of the dried clinical samples using a miniature mass spectrometer. The stability and sensitivity of the developed paper-based immunoassay platform would allow miniature mass spectrometers to be used for point-of-care malaria detection as well as in large-scale surveillance screening to aid eradication programs.
Microfluidic Immunoassay Market Opportunity
Increasing Demand for Point-of-Care Testing
Existing laboratory diagnostic technologies require sophisticated infrastructure, expensive reagents, stable electricity supply, long assay times, and trained staff. Also, laboratories and medical testing facilities are often limited and inaccessible to patients in remote areas. Hence, developing countries are increasingly facing the burden of infectious and non-communicable diseases, leading to high mortality. According to the WHO, globally, an estimated 1 billion cases of influenza are registered annually, with 3-5 million being severe cases. Deploying rapid and easy-to-use POC tests and microfluidics based POC tests in low-income countries can enable enhanced disease diagnosis on-site without the need for trained healthcare professionals.
Moreover, laboratory testing requires a significant amount of time and reagent consumption. For instance, urinalysis at a laboratory/medical testing facility takes 24–48 hours to deliver results. This time can be reduced considerably with the use of lab-on-chip POC tests. Thus, manufacturers of POC diagnostics, including microfluidic immunoassays, can expand to untapped markets in developing countries to leverage these opportunities.
Microfluidic Immunoassay Market Analysis: Key Findings
By Product: In 2024, the Microfluidic Cartridges Segment to Dominate the Microfluidic Immunoassay Market
Based on product, the microfluidic immunoassay market is segmented into consumables and systems. In 2024, the consumables segment is expected to account for the largest share of 69.6% of the microfluidic immunoassay market. The consumables segment is further segmented into microfluidic cartridges and reagents. The microfluidic cartridges segment is expected to account for the largest share. Cartridges have become essential tools for diagnosing various diseases. These assays are used for testing infectious diseases, cancer markers, cytokines, cardiac markers, autoimmune diseases, and endocrine diseases. Their increasing application areas in clinical diagnostics and R&D are driving the market's growth.
By Technology: In 2024, the Electrochemical Detection Segment to Dominate the Microfluidic Immunoassay Market
Based on technology, the microfluidic immunoassay market is segmented into electrochemical detection and optical detection. In 2024, the electrochemical detection segment is expected to account for the largest share of the microfluidic immunoassay market. Electrochemical detection has been widely employed in point-of-care testing owing to its cost efficiency, ability to analyze turbid samples, and adaptability for miniaturization. Electrochemical detection coupled with microfluidics is a promising detection technology for immunoassays owing to the benefits such as simple and portable assay, low sample consumption, low detection limit, and rapid method contributing to the largest share of the segment.
By Application: In 2024, the Cardiology Segment to Dominate the Microfluidic Immunoassay Market
Based on application, the global microfluidic immunoassay market is segmented into cardiology, infectious diseases, oncology, and other applications. In 2024, the cardiology segment is expected to account for the largest share of 53.5% of the microfluidic immunoassay market. Cardiac markers are released in the blood after injury to the heart muscles. These indicators are used as a measure to diagnose cardiovascular diseases. The rising prevalence of cardiovascular diseases is increasing the demand for microfluidic immunoassay detection kits. According to, American Heart Association (U.S.), a non-profit organization involved in consumer education about cardiovascular disease, more than 350,000 cardiac arrests occur outside the hospital each year. The microfluidic cartridges detects cardiac biomarkers for accurate diagnosis. The microfluidic cardiac biomarker tests are also used in the biomedical and clinical research. These biomarkers are objectively measured and used to indicate a certain biological state, whether physiological, pathological, or pharmacological, and gather information about normal molecular physiology as well as cardiovascular disease (CVD) activity and progression, which can further be used in drug discovery is further supporting the largest share of segment.
The oncology segment is expected to grow at the highest CAGR of 8.7% during the forecast period. The increasing prevalence of cancer (malignant tumor) and the development of microfluidic devices for the analysis of various biomarkers, including proteins, circulating tumor cells, exosomes, and cell-free DNA, contributed to the highest CAGR of the segment. For instance, cancer is a major health concern globally and is one of the leading causes of morbidity and mortality across the world. According to GLOBOCAN, the global burden of cancer is expected to increase from 19.3 million cases in 2020 to 24.6 million cases by 2030.
By End User: In 2024, the Pharmaceutical & Biotechnology Companies Segment to Dominate the Microfluidic Immunoassay Market
Based on end user, the microfluidic immunoassay market is segmented into pharmaceutical & biotechnology companies, diagnostic laboratories, hospitals, and other end users. In 2024, the pharmaceutical & biotechnology companies segment is expected to account for the largest share of the market. The rising number of research laboratories, increasing investment in R&D, and rising funding for research laboratories support the largest share of the market. The funding for research laboratories is increasing due to the increasing demand for new drugs and therapies.
Geographical Analysis
In 2024, North America to Dominate the Microfluidic Immunoassay Market
In 2024, North America is expected to account for the largest share of the 40.3% of microfluidic immunoassay market. The largest share of the region is attributed to rising government support and spending for research activities, rising R&D investment by pharmaceutical & biopharmaceutical companies, high number of laboratory tests performed annually, developed healthcare infrastructure in the region, the growing trend for self-testing, a high number of CLIA-waived tests, and increasing prevalence of chronic diseases. according to the WHO, new cancer cases in the U.S. are expected to increase from 2.2 million in 2020 to 2.7 million by 2030. Microfluidic immunoassays have a major application in cancer diagnosis and targeted therapy based on biomarkers. Therefore, the increasing prevalence of cancer is expected to propel the growth of the microfluidic immunoassay market in the region.
Moreover, the market in Asia-Pacific is slated to register the highest growth rate of 9.1% during the forecast period. The growth of the microfluidic immunoassay market in Asia-Pacific is attributed to the rising research funding in the healthcare and pharmaceutical industry, the rising number of research laboratories, the advancing research framework, and the growing number of diagnostic laboratories in countries such as China, India, Japan, South Korea, and others. For instance, in 2022, the R&D spending of BeiGene Ltd. (China), one of the major pharmaceutical companies, increased by 12.4% from 2021. The increasing use of microfluidic immunoassay in precision medicine and government initiatives for precision medicine is also driving the market growth.
Microfluidic Immunoassay Market: Key Companies
The report offers a competitive landscape based on an extensive assessment of the product offerings and geographic presence of leading market players and the key growth strategies adopted by them over the past few years (2021–2024). The report offers a competitive landscape based on an extensive assessment of the product portfolio offerings, geographic presences, and key strategic developments adopted by leading market players in the industry over the years (2021–2024). The key players operating in the global microfluidic immunoassay market are Becton, Dickinson and Company (U.S.), Revvity, Inc. (U.S.), Abbott Laboratories (U.S.), Siemens Healthineers AG (Germany), Nanomix Corporation (U.S.), Micropoint Biotechnologies Co., Ltd. (China), Biosurfit SA (Portugal), Koninklijke Philips N.V. (Netherland), NanoEnTek Inc. (South Korea), and QuidelOrtho Corporation (U.S.).
Microfluidic Immunoassay Market Overview: Latest Developments from Key Industry Players
- In March 2023, QuidelOrtho Corporation (U.S.) received a De Novo request from the U.S. Food and Drug Administration (FDA) for the marketing of Sofia 2 SARS Antigen+ FIA. The assay is a lateral flow (microfluidic) immunofluorescent sandwich assay used for the qualitative detection of the nucleocapsid protein antigen from SARS-CoV-2 in direct nasopharyngeal (NP) and nasal (NS) swab specimens.
- In November 2022, Nanomix Corp. (U.S.) entered into a distribution agreement with Gepa Srl (Italy). The agreement is for the distribution of the eLab system in Italy.
- In November 2022, LumiraDx Healthcare Pvt Ltd (India) launched a C-Reactive protein point of care antigen test in India. The test gives result in four minutes. The test is used to combat antimicrobial resistance in India.
- In October 2022, Micropoint Biotechnologies Co., Ltd. (China) received a CE marking for the Micropoint COVID-19 Ag test.
Microfluidic Immunoassay Market Research Summary
|
Particulars |
Details |
|
Number of Pages |
 259 |
|
Format |
 PDF |
|
Forecast Period |
 2024-2031 |
|
Base Year |
 2023 |
|
CAGR |
 7.3% |
|
Estimated Market Size (Value) |
 $1.59 billion by 2031 |
|
Segments Covered |
By Product
By Technology
By Application
By End User
|
|
Countries Covered |
North America (U.S. and Canada), Europe (Germany, France, U.K., Italy, Spain, and Rest of Europe), Asia-Pacific (China, Japan, India, and Rest of Asia-Pacific), Latin America, and Middle East & Africa |
|
Key Companies |
The key players operating in the global microfluidic immunoassay market are Becton, Dickinson and Company (U.S.), Revvity, Inc. (U.S.), Abbott Laboratories (U.S.), Siemens Healthineers AG (Germany), Nanomix Corporation (U.S.), Micropoint Biotechnologies Co., Ltd. (China), Biosurfit SA (Portugal), Koninklijke Philips N.V. (Netherland), NanoEnTek Inc. (South Korea), and QuidelOrtho Corporation (U.S.). |
Key questions answered in the microfluidic immunoassay market report:
The global microfluidic immunoassay market covers the study of various microfluidic immunoassay cartridges, reagents, and systems used in various application areas at the regional and country levels. The report also provides insights on factors impacting market growth, regulatory analysis, pricing analysis, and Porter’s five forces analysis.
The global microfluidic immunoassay market is projected to reach $1.59 billion by 2031 at a CAGR of 7.3% during the forecast period.
Among the products, the consumables segment is expected to hold a major market share of 69.6% of the microfluidic immunoassay market in 2024. The largest market share is attributed to the reduced manual errors with the use of microfluidic cartridges, integration of several tests on a single cartridge, rapid reaction time, integration of lab procedures on a single device, higher analytical sensitivity, portability, improved temperature control, and easier parallelization and automation.
The growth of this market is attributed to several factors; the growth of this market is driven by the increasing use of microfluidic immunoassays in drug discovery & development and biomarker detection, the advantages of lab-on-chip immunoassays over conventional immunoassays, pharmaceutical & biotechnology companies’ increasing focus on research & development, and the miniaturization of biological and chemical assays.
The key players operating in the global microfluidic immunoassay market are Becton, Dickinson and Company (U.S.), Revvity, Inc. (U.S.), Abbott Laboratories (U.S.), Siemens Healthineers AG (Germany), Nanomix Corporation (U.S.), Micropoint Biotechnologies Co., Ltd. (China), Biosurfit SA (Portugal), Koninklijke Philips N.V. (Netherland), NanoEnTek Inc. (South Korea), and QuidelOrtho Corporation (U.S.).
The growth of the microfluidic immunoassay market in Asia-Pacific is attributed to the rising research funding in the healthcare and pharmaceutical industry, the rising number of research laboratories, the advancing research framework, and the growing number of diagnostic laboratories in countries such as China, India, Japan, South Korea, and others. For instance, in 2022, the R&D spending of BeiGene Ltd. (China), one of the major pharmaceutical companies, increased by 12.4% from 2021.
1Â Â Â Introduction
   1.1.   Market Definition & Scope
   1.2.   Market Ecosystem
   1.3.   Currency & Limitations
   1.4.   Key Stakeholders
2.  Research Methodology
   2.1.   Research Approach
   2.2.   Process of Data Collection and Validation
         2.2.1.   Secondary Research
         2.2.2.   Primary Research/Interviews with Key Opinion Leaders of the Industry
   2.3.   Market Sizing and Forecasting
         2.3.1.   Market Size Estimation Approach
         2.3.2.   Growth Forecast Approach
   2.4.   Assumptions for the Study
3.  Executive Summary
4Â Â Â Market Insights
   4.1.   Overview
   4.2.   Factors Affecting Market Growth
         4.2.1.   Impact Analysis of Market Dynamics
               4.2.1.1.   Increasing Use of Microfluidic Immunoassays in Drug Discovery & Development and Biomarker Detection Driving Market Growth
               4.2.1.2.   Bubble Formation and Dead Volume Limiting the Adoption of Microfluidics Devices
               4.2.1.3.   Increasing Demand for Point-of-Care Testing Generating Growth Opportunities for Market Players
               4.2.1.4.   Selecting Suitable Substrate Materials to Design Microfluidic Chips to Remain a Major Challenge for Market Players
         4.2.2.   Factor Analysis
   4.3.   Technology Trends
         4.3.1.   Multiplexed Panel Detection
         4.3.2.   Paper-Based Microfluidics
   4.4.   Regulatory Analysis
         4.4.1.   North America
               4.4.1.1.   U.S.
               4.4.1.2.   Canada
         4.4.2.   Europe
         4.4.3.   Asia-Pacific
               4.4.3.1.   China
               4.4.3.2.   Japan
               4.4.3.3.   India
         4.4.4.   Latin America
         4.4.5.   Middle EastÂ
               4.4.5.1.   Saudi Arabia
   4.5.   Pricing Analysis
   4.6.   Porter’s Five Forces Analysis
         4.6.1.   Bargaining Power of Suppliers
         4.6.2.   Bargaining Power of Buyers
         4.6.3.   Threat of Substitutes
         4.6.4.   Threat of New Entrants
         4.6.5.   Degree of Competition
5.  Microfluidic Immunoassay Market Assessment—by Product
   5.1.   Overview  Â
   5.2.   Consumables
         5.2.1.   Cartridges
               5.2.1.1.   Polymer
               5.2.1.2.   Glass
               5.2.1.3.   Silicon
         5.2.2.   Reagents
   5.3.   Systems
6.  Microfluidic Immunoassay Market Assessment—by Technology
   6.1.   Overview
   6.2.   Electrochemical Detection
   6.3.   Optical Detection
7.  Microfluidic Immunoassay Market Assessment—by Application
   7.1.   Overview
   7.2.   Cardiology
         7.2.1.   Single Biomarker Detection
         7.2.2.   Multiplexed Biomarker Detection
   7.3.   Infectious Diseases
   7.4.   Oncology
   7.5.   Other Applications
8.  Microfluidic Immunoassay Market Assessment—by End User  Â
   8.1.   Overview
   8.2.   Pharmaceutical & Biotechnology Companies
   8.3.   Diagnostic Laboratories
   8.4.   Hospital
   8.5.   Other End Users
9.  Microfluidic Immunoassay Market Assessment—by Geography
   9.1.   Overview
   9.2.   North America
         9.2.1.   U.S.
         9.2.2.   Canada
   9.3.   Europe
         9.3.1.   Germany
         9.3.2.   France
         9.3.3.   U.K.
         9.3.4.   Italy
         9.3.5.   Spain  Â
         9.3.6.   Rest of Europe
   9.4.   Asia-Pacific
         9.4.1.   China  Â
         9.4.2.   Japan
         9.4.3.   India  Â
9.4.4.   Rest of Asia-Pacific
   9.5.   Latin America  Â
   9.6.   Middle East & Africa
10.  Competition Analysis
     10.1.   Overview
     10.2.   Key Growth Strategies
     10.3.   Competitive Benchmarking
     10.4.   Competitive Dashboard
           10.4.1.   Industry Leaders
           10.4.2.   Differentiators  Â
           10.4.3.   Vanguards
           10.4.4.   Emerging Companies
11.  Company Profiles (Company Overview, Financial Snapshot, Product Portfolio, and Strategic Developments)
     11.1.   Abbott Laboratories
     11.2.   Revvity, Inc. (Formerly PerkinElmer, Inc.)
     11.3.   Siemens Healthineers AG.
     11.4.   QuidelOrtho Corporation.
     11.5.   Nanomix, Inc.
     11.6.   Becton, Dickinson and Company  Â
     11.7.   Micropoint Biotechnologies Co., Ltd.  Â
     11.8.   Biosurfit SA
     11.9.   Koninklijke Philips N.V.
     11.10.   NanoEnTek Inc.
            (Note: SWOT Analysis of the Top 5 Companies Will Be Provided)
12.  Appendix
     12.1.   Available Customization  Â
     12.2.   Related Reports  Â
List of Tables
Table 1Â Â Â Funding for Microfluidic Immunoassay Research & Development
Table 2Â Â Â Estimated Number of New Cancer Cases, by Type (2020 Vs. 2030)
Table 3   Research Studies on Paper-Based Microfluidics, 2017–2023
Table 4Â Â Â Authorities Regulating In Vitro Diagnostic Products, by Country/Region
Table 5Â Â Â Medical Devices Regulatory Authorities in the Rest of APAC Countries
Table 6Â Â Â Average Selling Prices of Microfluidic Immunoassay Products (USD/Unit)
Table 7Â Â Â Quidelortho Corporation (U.S.): Product Pricing (USD/Unit)
Table 8Â Â Â Abbott Laboratories (U.S.): Product Pricing (USD/Unit)
Table 9Â Â Â Global Microfluidic Immunoassay Market, by Product, 2022-2031 (USD Million)
Table 10Â Â Â Global Microfluidic Immunoassay Consumables Market, by Type, 2022-2031 (USD Million)Â Â Â
Table 11   Global Microfluidic Immunoassay Consumables Market, by Country/Region, 2022–2031 (USD Million)
Table 12Â Â Â Global Microfluidic Immunoassay Cartridges Market, by Material, 2022-2031 (USD Million)
Table 13   Global Microfluidic Immunoassay Cartridges Market, by Country/Region, 2022–2031 (USD Million)  Â
Table 14   Global Polymer-Based Microfluidic Immunoassay Cartridges Market, by Country/Region, 2022–2031 (USD Million)  Â
Table 15   Global Glass-Based Microfluidic Immunoassay Cartridges Market, by Country/Region, 2022–2031 (USD Million)
Table 16   Global Silicon-Based Microfluidic Immunoassay Cartridges Market, by Country/Region, 2022–2031 (USD Million)
Table 17   Global Microfluidic Immunoassay Reagents Market, by Country/Region, 2022–2031 (USD Million)  Â
Table 18   Global Microfluidic Immunoassay Systems Market, by Country/Region, 2022–2031 (USD Million)  Â
Table 19Â Â Â Global Microfluidic Immunoassay Market, by Technology, 2022-2031 (USD Million)Â Â Â
Table 20   Global Microfluidic Immunoassay Market for Electrochemical Detection, by Country/Region, 2022–2031 (USD Million)  Â
Table 21Â Â Â Optical Detection Techniques for Microfluidic Applications
Table 22   Global Microfluidic Immunoassay Market for Optical Detection, by Country/Region, 2022–2031 (USD Million)  Â
Table 23Â Â Â Global Microfluidic Immunoassay Market, by Application, 2022-2031 (USD Million)
Table 24Â Â Â Clinically Significant Cardiac Biomarkers
Table 25Â Â Â Global Microfluidic Immunoassay Market for Cardiology, by Type, 2022-2031 (USD Million)
Table 26   Global Microfluidic Immunoassay Market for Cardiology, by Country/Region, 2022–2031 (USD Million)
Table 27Â Â Â Commercially Available Tests for Single Cardiac Biomarker Detection
Table 28   Global Microfluidic Immunoassay Market for Single Biomarker Detection, by Country/Region, 2022–2031 (USD Million)
Table 29Â Â Â Commercially Available Tests for Multiplexed Cardiac Biomarker Detection
Table 30   Global Microfluidic Immunoassay Market for Multiplexed Biomarker Detection, by Country/Region, 2022–2031 (USD Million)
Table 31   Global Microfluidic Immunoassay Market for Infectious Disease, by Country/Region, 2022–2031 (USD Million)
Table 32Â Â Â Clinically Significant Oncology Biomarkers
Table 33   Global Microfluidic Immunoassay Market for Oncology, by Country/Region, 2022–2031 (USD Million)
Table 34Â Â Â Commercially Available Tests for Diabetes Biomarker Detection
Table 35   Global Microfluidic Immunoassay Market for Other Applications, by Country/Region, 2022–2031 (USD Million)
Table 36Â Â Â Global Microfluidic Immunoassay Market, by End User, 2022-2031 (USD Million)
Table 37   Global Microfluidic Immunoassay Market for Pharmaceutical & Biotechnology Companies, by Country/Region, 2022–2031 (USD Million)
Table 38   Global Microfluidic Immunoassay Market for Diagnostic Laboratories, by Country/Region, 2022–2031 (USD Million)
Table 39   Global Microfluidic Immunoassay Market for Hospitals, by Country/Region, 2022–2031 (USD Million)
Table 40   Global Microfluidic Immunoassay Market for Other End Users, by Country/Region, 2022–2031 (USD Million)
Table 41Â Â Â Global Microfluidic Immunoassay Market, by Country/Region, 2022-2031 (USD Million)
Table 42   North America: Microfluidic Immunoassay Market, by Country, 2022–2031 (USD Million)
Table 43   North America: Microfluidic Immunoassay Market, by Product, 2022–2031 (USD Million)
Table 44   North America: Microfluidic Immunoassay Consumables Market, by Type, 2022–2031 (USD Million)  Â
Table 45   North America: Microfluidic Immunoassay Cartridges Market, by Material, 2022–2031 (USD Million)  Â
Table 46   North America: Microfluidic Immunoassay Market, by Technology, 2022–2031 (USD Million)
Table 47   North America: Microfluidic Immunoassay Market, by Application, 2022–2031 (USD Million)
Table 48   North America: Microfluidic Immunoassay Market for Cardiology, by Type, 2022–2031 (USD Million)
Table 49   North America: Microfluidic Immunoassay Market, by End User, 2022–2031 (USD Million)
Table 50   U.S.: Microfluidic Immunoassay Market, by Product, 2022–2031 (USD Million)
Table 51   U.S.: Microfluidic Immunoassay Consumables Market, by Type, 2022–2031 (USD Million)
Table 52   U.S.: Microfluidic Immunoassay Cartridges Market, by Material, 2022–2031 (USD Million)
Table 53   U.S.: Microfluidic Immunoassay Market, by Technology, 2022–2031 (USD Million)
Table 54   U.S.: Microfluidic Immunoassay Market, by Application, 2022–2031 (USD Million)
Table 55   U.S.: Microfluidic Immunoassay Market for Cardiology, by Type, 2022–2031 (USD Million)
Table 56   U.S.: Microfluidic Immunoassay Market, by End User, 2022–2031 (USD Million)
Table 57   Canada: Microfluidic Immunoassay Market, by Product, 2022–2031 (USD Million)
Table 58   Canada: Microfluidic Immunoassay Consumables Market, by Type, 2022–2031 (USD Million)
Table 59   Canada: Microfluidic Immunoassay Cartridges Market, by Material, 2022–2031 (USD Million)
Table 60   Canada: Microfluidic Immunoassay Market, by Technology, 2022–2031 (USD Million)  Â
Table 61   Canada: Microfluidic Immunoassay Market, by Application, 2022–2031 (USD Million)
Table 62   Canada: Microfluidic Immunoassay Market for Cardiology, by Type, 2022–2031 (USD Million)
Table 63   Canada: Microfluidic Immunoassay Market, by End User, 2022–2031 (USD Million)
Table 64   Europe: Microfluidic Immunoassay Market, by Country/Region, 2022–2031 (USD Million
Table 65   Europe: Microfluidic Immunoassay Market, by Product, 2022–2031 (USD Million)
Table 66   Europe: Microfluidic Immunoassay Consumables Market, by Type, 2022–2031 (USD Million)
Table 67   Europe: Microfluidic Immunoassay Cartridges Market, by Material, 2022–2031 (USD Million)
Table 68   Europe: Microfluidic Immunoassay Market, by Technology, 2022–2031 (USD Million)  Â
Table 69   Europe: Microfluidic Immunoassay Market, by Application, 2022–2031 (USD Million)  Â
Table 70   Europe: Microfluidic Immunoassay Market for Cardiology, by Type, 2022–2031 (USD Million)
Table 71   Europe: Microfluidic Immunoassay Market, by End User, 2022–2031 (USD Million)
Table 72   Germany: Microfluidic Immunoassay Market, by Product, 2022–2031 (USD Million)
Table 73   Germany: Microfluidic Immunoassay Consumables Market, by Type, 2022–2031 (USD Million)
Table 74   Germany: Microfluidic Immunoassay Cartridges Market, by Material, 2022–2031 (USD Million)
Table 75   Germany: Microfluidic Immunoassay Market, by Technology, 2022–2031 (USD Million
Table 76   Germany: Microfluidic Immunoassay Market, by Application, 2022–2031 (USD Million)
Table 77   Germany: Microfluidic Immunoassay Market for Cardiology, by Type, 2022–2031 (USD Million)
Table 78   Germany: Microfluidic Immunoassay Market, by End User, 2022–2031 (USD Million)
Table 79   France: Microfluidic Immunoassay Market, by Product, 2022–2031 (USD Million)
Table 80   France: Microfluidic Immunoassay Consumables Market, by Type, 2022–2031 (USD Million)
Table 81   France: Microfluidic Immunoassay Cartridges Market, by Material, 2022–2031 (USD Million)
Table 82   France: Microfluidic Immunoassay Market, by Technology, 2022–2031 (USD Million)  Â
Table 83   France: Microfluidic Immunoassay Market, by Application, 2022–2031 (USD Million)  Â
Table 84   France: Microfluidic Immunoassay Market for Cardiology, by Type, 2022–2031 (USD Million)
Table 85   France: Microfluidic Immunoassay Market, by End User, 2022–2031 (USD Million)
Table 86   U.K.: Microfluidic Immunoassay Market, by Product, 2022–2031 (USD Million)
Table 87   U.K.: Microfluidic Immunoassay Consumables Market, by Type, 2022–2031 (USD Million)
Table 88   U.K.: Microfluidic Immunoassay Cartridges Market, by Material, 2022–2031 (USD Million)
Table 89   U.K.: Microfluidic Immunoassay Market, by Technology, 2022–2031 (USD Million)
Table 90   U.K.: Microfluidic Immunoassay Market, by Application, 2022–2031 (USD Million)
Table 91   U.K.: Microfluidic Immunoassay Market for Cardiology, by Type, 2022–2031 (USD Million)
Table 92   U.K.: Microfluidic Immunoassay Market, by End User, 2022–2031 (USD Million)
Table 93   Italy: Microfluidic Immunoassay Market, by Product, 2022–2031 (USD Million)
Table 94   Italy: Microfluidic Immunoassay Consumables Market, by Type, 2022–2031 (USD Million)
Table 95Â Â Â Italy: Microfluidic Immunoassay Cartridges Market, by Material, 2022-2031 (USD Million)
Table 96   Italy: Microfluidic Immunoassay Market, by Application, 2022–2031 (USD Million)
Table 97   Italy: Microfluidic Immunoassay Market for Cardiology, by Type, 2022–2031 (USD Million)
Table 98   Italy: Microfluidic Immunoassay Market, by End User, 2022–2031 (USD Million)
Table 99   Spain: Microfluidic Immunoassay Market, by Product, 2022–2031 (USD Million)
Table 100   Spain: Microfluidic Immunoassay Consumables Market, by Type, 2022–2031 (USD Million)
Table 101   Spain: Microfluidic Immunoassay Cartridges Market, by Material, 2022–2031 (USD Million)
Table 102   Spain: Microfluidic Immunoassay Market, by Technology, 2022–2031 (USD Million)
Table 103   Spain: Microfluidic Immunoassay Market, by Application, 2022–2031 (USD Million)
Table 104   Spain: Microfluidic Immunoassay Market for Cardiology, by Type, 2022–2031 (USD Million)
Table 105   Spain: Microfluidic Immunoassay Market, by End User, 2022–2031 (USD Million)
Table 106Â Â Â Covid-19 Cases in European Countries
Table 107   Rest of Europe: Microfluidic Immunoassay Market, by Product, 2022–2031 (USD Million)
Table 108   Rest of Europe: Microfluidic Immunoassay Consumables Market, by Type, 2022–2031 (USD Million)  Â
Table 109   Rest of Europe: Microfluidic Immunoassay Cartridges Market, by Material, 2022–2031 (USD Million)  Â
Table 110   Rest of Europe: Microfluidic Immunoassay Market, by Technology, 2022–2031 (USD Million)
Table 111   Rest of Europe: Microfluidic Immunoassay Market, by Application, 2022–2031 (USD Million)
Table 112   Rest of Europe: Microfluidic Immunoassay Market for Cardiology, by Type, 2022–2031 (USD Million)  Â
Table 113   Rest of Europe: Microfluidic Immunoassay Market, by End User, 2022–2031 (USD Million)
Table 114   Asia-Pacific: Microfluidic Immunoassay Market, by Country/Region, 2022–2031 (USD Million)
Table 115   Asia-Pacific: Microfluidic Immunoassay Market, by Product, 2022–2031 (USD Million)
Table 116   Asia-Pacific: Microfluidic Immunoassay Consumables Market, by Type, 2022–2031 (USD Million)
Table 117   Asia-Pacific: Microfluidic Immunoassay Cartridges Market, by Material,2022–2031 (USD Million)  Â
Table 118   Asia-Pacific: Microfluidic Immunoassay Market, by Technology, 2022–2031 (USD Million)
Table 119   Asia-Pacific: Microfluidic Immunoassay Market, by Application, 2022–2031 (USD Million)
Table 120   Asia-Pacific: Microfluidic Immunoassay Market for Cardiology, by Type, 2022–2031 (USD Million)  Â
Table 121   Asia-Pacific: Microfluidic Immunoassay Market, by End User, 2022–2031 (USD Million)  Â
Table 122   China: Microfluidic Immunoassay Market, by Product, 2022–2031 (USD Million)
Table 123   China: Microfluidic Immunoassay Consumables Market, by Type, 2022–2031 (USD Million)
Table 124   China: Microfluidic Immunoassay Cartridges Market, by Material, 2022–2031 (USD Million)
Table 125   China: Microfluidic Immunoassay Market, by Technology, 2022–2031 (USD Million)
Table 126   China: Microfluidic Immunoassay Market, by Application, 2022–2031 (USD Million)
Table 127   China: Microfluidic Immunoassay Market for Cardiology, by Type, 2022–2031 (USD Million)
Table 128   China: Microfluidic Immunoassay Market, by End User, 2022–2031 (USD Million)
Table 129   Japan: Microfluidic Immunoassay Market, by Product, 2022–2031 (USD Million)
Table 130   Japan: Microfluidic Immunoassay Consumables Market, by Type, 2022–2031 (USD Million)
Table 131   Japan: Microfluidic Immunoassay Cartridges Market, by Material, 2022–2031 (USD Million)
Table 132   Japan: Microfluidic Immunoassay Market, by Technology, 2022–2031 (USD Million)  Â
Table 133   Japan: Microfluidic Immunoassay Market, by Application, 2022–2031 (USD Million)
Table 134   Japan: Microfluidic Immunoassay Market for Cardiology, by Type, 2022–2031 (USD Million)
Table 135   Japan: Microfluidic Immunoassay Market, by End User, 2022–2031 (USD Million)
Table 136   India: Microfluidic Immunoassay Market, by Product, 2022–2031 (USD Million)
Table 137   India: Microfluidic Immunoassay Consumables Market, by Type, 2022–2031 (USD Million)
Table 138   India: Microfluidic Immunoassay Cartridges Market, by Material, 2022–2031 (USD Million)
Table 139   India: Microfluidic Immunoassay Market, by Technology, 2022–2031 (USD Million)
Table 140   India: Microfluidic Immunoassay Market, by Application, 2022–2031 (USD Million)
Table 141   India: Microfluidic Immunoassay Market for Cardiology, by Type, 2022–2031 (USD Million)
Table 142   India: Microfluidic Immunoassay Market, by End User, 2022–2031 (USD Million)
Table 143   Rest of Asia-Pacific: Microfluidic Immunoassay Market, by Product, 2022–2031 (USD Million)
Table 144   Rest of Asia-Pacific: Microfluidic Immunoassay Consumables Market, by Type, 2022–2031 (USD Million)
Table 145   Rest of Asia-Pacific: Microfluidic Immunoassay Cartridges Market, by Material, 2022–2031 (USD Million)
Table 146   Rest of Asia-Pacific: Microfluidic Immunoassay Market, by Technology, 2022–2031 (USD Million)
Table 147   Rest of Asia-Pacific: Microfluidic Immunoassay Market, by Application, 2022–2031 (USD Million)
Table 148   Rest of Asia-Pacific: Microfluidic Immunoassay Market for Cardiology, by Type, 2022–2031 (USD Million)
Table 149   Rest of Asia-Pacific: Microfluidic Immunoassay Market, by End User, 2022–2031 (USD Million)
Table 150   Latin America: Microfluidic Immunoassay Market, by Product, 2022–2031 (USD Million)  Â
Table 151   Latin America: Microfluidic Immunoassay Consumables Market, by Type, 2022–2031 (USD Million)  Â
Table 152   Latin America: Microfluidic Immunoassay Cartridges Market, by Material, 2022–2031 (USD Million)  Â
Table 153   Latin America: Microfluidic Immunoassay Market, by Technology, 2022–2031 (USD Million)
Table 154   Latin America: Microfluidic Immunoassay Market, by Application, 2022–2031 (USD Million)
Table 155   Latin America: Microfluidic Immunoassay Market for Cardiology, by Type, 2022–2031 (USD Million)  Â
Table 156   Latin America: Microfluidic Immunoassay Market, by End User, 2022–2031 (USD Million)
Table 157Â Â Â Saudi Arabia, South Africa, and UAE Estimated Cancer Incidence
Table 158   Middle East & Africa: Microfluidic Immunoassay Market, by Product, 2022–2031 (USD Million)
Table 159   Middle East & Africa: Microfluidic Immunoassay Consumables Market, by Type, 2022–2031 (USD Million)
Table 160   Middle East & Africa: Microfluidic Immunoassay Cartridges Market, by Material, 2022–2031 (USD Million)
Table 161   Middle East & Africa: Microfluidic Immunoassay Market, by Technology, 2022–2031 (USD Million)  Â
Table 162   Middle East & Africa: Microfluidic Immunoassay Market, by Application, 2022–2031 (USD Million)  Â
Table 163   Middle East & Africa: Microfluidic Immunoassay Market for Cardiology, by Type, 2022–2031 (USD Million)
Table 164   Middle East & Africa: Microfluidic Immunoassay Market, by End User, 2022–2031 (USD Million)
Table 165   Recent Developments, by Company, 2020–2024
List of Figures
Figure 1Â Â Â Research Process
Figure 2Â Â Â Secondary Sources Referenced for This Study
Figure 3Â Â Â Primary Research Techniques
Figure 4Â Â Â Key Executives Interviewed
Figure 5Â Â Â Breakdown of Primary Interviews (Supply Side & Demand Side)
Figure 6Â Â Â Market Sizing and Growth Forecast Approach
Figure 7Â Â Â Global Microfluidic Immunoassay Market, by Product, 2024 Vs. 2031 (USD Million)Â Â Â
Figure 8Â Â Â Global Microfluidic Immunoassay Market, by Technology, 2024 Vs. 2031 (USD Million)
Figure 9Â Â Â Global Microfluidic Immunoassay Market, by Application, 2024 Vs. 2031 (USD Million)
Figure 10Â Â Â Global Microfluidic Immunoassay Market, by End User, 2024 Vs. 2031 (USD Million)Â Â Â
Figure 11Â Â Â Microfluidic Immunoassay Market, by Geography
Figure 12Â Â Â Impact Analysis of Market Dynamics
Figure 13   Global Pharmaceutical R&D Expenditure, 2012–2026 (USD Billion)
Figure 14Â Â Â Eu Regulatory Pathway - IVDR 2017/746
Figure 15   Porter’s Five Forces Analysis
Figure 16Â Â Â Global Microfluidic Immunoassay Market, by Product, 2024 Vs. 2031 (USD Million)Â Â Â
Figure 17Â Â Â Global Microfluidic Immunoassay Market, by Technology, 2024 Vs. 2031 (USD Million)
Figure 18Â Â Â Global Microfluidic Immunoassay Market, by Application, 2024 Vs. 2031 (USD Million)
Figure 19Â Â Â Global Microfluidic Immunoassay Market, by End User, 2024 Vs. 2031 (USD Million)Â Â Â
Figure 20   Global Pharmaceutical R&D Spending, 2012–2026 (USD Billion)
Figure 21Â Â Â Global Microfluidic Immunoassay Market, by Region, 2024 Vs. 2031 (USD Million)
Figure 22   North America: Number of People Aged 65 Years and Above, 2015–2021 (In Million)
Figure 23Â Â Â North America: Microfluidic Immunoassay Market Snapshot
Figure 24   U.S.: Pharmaceutical R&D Expenditure, 2014–2021 (USD Billion)
Figure 25   Europe: Pharmaceutical Industry R&D Expenditure, 2000–2021 (USD Million)
Figure 26Â Â Â Europe: Microfluidic Immunoassay Market Snapshot
Figure 27   U.K: Estimated Number of Cancer Cases, 2020–2030
Figure 28Â Â Â Pharmaceutical R&D Expenditure, by Country, 2020 (USD Million)
Figure 29Â Â Â Asia-Pacific: Microfluidic Immunoassay Market Snapshot
Figure 30   Key Growth Strategies Adopted by Leading Players, 2020–2024
Figure 31Â Â Â Microfluidic Immunoassay Market: Competitive Benchmarking (Based on Product)Â Â Â
Figure 32Â Â Â Microfluidic Immunoassay Market: Competitive Benchmarking (Based on Geography)
Figure 33Â Â Â Competitive Dashboard: Microfluidic Immunoassay Market
Figure 34Â Â Â Abbott Laboratories: Financial Overview (2023)
Figure 35Â Â Â PerkinElmer, Inc.: Financial Overview (2023)
Figure 36Â Â Â Siemens Healthineers AG: Financial Overview (2023)
Figure 37Â Â Â QuidelOrtho Corporation: Financial Snapshot (2023)
Figure 38Â Â Â Nanomix, Inc.: Financial Overview (2023)
Figure 39Â Â Â Becton, Dickinson and Company: Financial Overview (2023)
Figure 40Â Â Â Koninklijke Philips N.V.: Financial Snapshot (2023)
Figure 41Â Â Â NanoEnTek Inc.: Financial Snapshot (2023)Â Â Â
Author Name:
Proudly Partnering With Enterprises Around the Globe
Quick Contact
Related Reports
Life Science Equipment Market - Global Opportunity Analysis and Industry Forecast (2024-2031)
Published Date: Jan-2024
Latin America PoC Diagnostics Market - Opportunity Analysis and Industry Forecast (2020-2027)
Published Date: Jul-2020
Asia-Pacific IVD Market - Opportunity Analysis and Industry Forecasts (2024-2031)
Published Date: Jan-2024
Middle East IVD Market - Opportunity Analysis and Industry Forecast (2024-2031)
Published Date: Jan-2024
